Results 11 to 20 of about 99,664 (224)
Protective Effects of Prophylactic and Therapeutic Erythromycin Administration in Ovarian Ischemia–Reperfusion Injury in Rats [PDF]
MedicinaBackground and Objectives: Ovarian ischemia–reperfusion (I/R) injury involves oxidative stress, inflammation, and structural tissue damage that may impair ovarian function.
Sümeyye Akyüz +4 more
doaj +2 more sources
Agent, Dose and Duration: The Unanswered Questions Behind Latency Antibiotic Therapy for Preterm Prelabour Rupture of Membranes [PDF]
AntibioticsLatency antibiotic therapy is an established component of expectant management after preterm prelabour rupture of membranes (PPROMs). Pooled randomised evidence from 22 trials involving 6872 women and infants shows that antibiotics prolong pregnancy ...
Iustina Petra Solomon Condriuc +6 more
doaj +2 more sources
Coronavirus (SARS-CoV-2) Deactivation via Spike Glycoprotein Shielding by Old Drugs: Molecular Docking Approach [PDF]
Journal of Epigenetics, 2021 Today the disease of COVID-19 comprises the most serious problem against human health worldwide with a high rate of virulence and mortality. The disease is caused by the SARS-CoV-2 virus from the beta coronavirus family.
Mohammad Reza Dayer
doaj +1 more source
Antibiotics, 2023 Background: Studies have demonstrated that the gut microbiome changes upon exposure to systemic antibiotics. There is a paucity of literature regarding impact on the gut microbiome by long-term usage of erythromycin ethyl succinate (EES) when utilized as
Aravind Thavamani +6 more
doaj +1 more source
Future Science OA, 2021 Aim: Resistance to methicillin and Macrolide–Lincosamide and Streptogramins B and their association with erm genes in Staphylococcus aureus are unknown in Nepal.
Roshan Timsina +3 more
doaj +1 more source
Erythromycin or Clindamycin – is it Still an Empirical Therapy against Streptococcus agalactiae in Patients Allergic to Penicillin? [PDF]
Polish Journal of Microbiology, 2017 Retrospective analysis of Streptococcus agalactiae antibiotic susceptibility isolated in 2010–2013 was performed. Penicillin was still the first-line antibiotic.
Piotr Leszczyński +4 more
doaj +1 more source
Erythromycin Formulations—A Journey to Advanced Drug Delivery
Pharmaceutics, 2022 Erythromycin (ERY) is a macrolide compound with a broad antimicrobial spectrum which is currently being used to treat a large number of bacterial infections affecting the skin, respiratory tract, intestines, bones and other systems, proving great value ...
Vera-Maria Platon +2 more
doaj +1 more source
Clinical Case Reports, 2023 The negative effects of anticoagulants are well‐known in patients with renal impairment, drug–drug interaction, lower physical conditions, and multiple comorbidities. We highlight that even in patients with controllable multiple risks for rivaroxaban use,
Kurumi Abe +6 more
doaj +1 more source
Acid degradation of erythromycin A and erythromycin B [PDF]
Experientia, 1971 Es wird die Bildung der 8,9-Anhydroerythromycin A und B 6, 9-Hemiketale aus den entsprechenden Erythromycinen mit Essigsaure bewiesen.
P, Kurath +3 more
openaire +2 more sources